All these data confirmed that the AKT pathway plays a key role in conferring an aggressive phenotype to cancer cells, with the promotion of cell survival and migration and its inhibition, reproduced in gastric cancer cell line treated with LY294002, could be an important anti-cancer therapy. This evidence concerns the gene AKT1 and gastric cancer.